Holen Sie sich die Stockscreener-App
3.52
0.41%
-0.0146
Handel nachbörslich:
3.52
Schlusskurs vom Vortag:
$3.5346
Offen:
$3.5
24-Stunden-Volumen:
1,308
Relative Volume:
0.13
Marktkapitalisierung:
$3.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.29M
KGV:
-0.6769
EPS:
-5.2
Netto-Cashflow:
$-9.42M
1W Leistung:
-0.62%
1M Leistung:
+4.64%
6M Leistung:
-18.07%
1J Leistung:
-26.51%
1-Tages-Spanne:
$3.47
$3.52
1-Wochen-Bereich:
$3.46
$3.6831
52-Wochen-Spanne:
$2.23
$8.92
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
Firmenname
Scinai Immunotherapeutics Ltd Adr
Sektor
Branche
Telefon
972-8-9302529
Adresse
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Vergleichen Sie SCNI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
3.52 | 3.00M | 0 | -9.29M | -9.42M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scinai Immunotherapeutics Ltd Adr Aktie (SCNI) Neueste Nachrichten
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 - Barchart
Scinai Regains Full Compliance with Nasdaq Listing Requirements - Benzinga
Scinai secures $2 million investment commitment By Investing.com - Investing.com India
Scinai reports promising psoriasis treatment study - Investing.com
Scinai reports Q1 results, progresses in pipeline By Investing.com - Investing.com South Africa
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Scinai Immunotherapeutics Ltd Adr-Aktie (SCNI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):